Featured Posts
Study
A Free Market is the Best Medicine
Introduction The pharmaceutical supply market is seeing extraordinarily high levels of innovation and consumer-benefiting evolution. The combination of a competitive market for generic drugs, rapid…
Blog
Congress considers micromanaging PBM finances
With the first reconciliation bill behind it, Congress is now looking to reform other aspects of the health care system. Pharmacy Benefit Manager (PBM)…
Blog
Free the Economy podcast: Drug costs and benefits with Sally Pipes
In this week’s episode we cover reforms to the Endangered Species Act, attacks on US tech firms, nuclear power innovation,…
Search Posts
Blog
Congress Could Give Desperate Patients ‘Right to Try’ Experimental Medications
The House of Representatives will soon vote on a companion bill to S. 204, the Right to Try Act. This bill would prevent the…
U.S. News & World Report
Don’t Blunt the Marijuana Revolution
U.S. News & World Report covers the coalition letter, led by CEI, advocating for the Rohrabacher medical marijuana amendment. America is undergoing a somewhat…
Blog
Ohio Drug Price Initiative Gives Taxpayer Money to Unnecessary Lawyers
Lawyers and allied interest groups have long enriched themselves at taxpayers’ expense. But usually, it has been by bringing lawsuits, not defending them.
VapingPost
In-Flight Vaping Ban Upheld
VapingPost covers CEI’s objection to a DOT vaping ban on airplanes. In another blow to American vapers, the Consumer Advocates for Smoke-free…
The Hill
The FDA Shouldn’t Give Into Irrational E-Cigarette Fears
The Food and Drug Administration is now on the wrong side of a new anti-vaping campaign. Instead of helping teens reject using tobacco or e-cigarettes,…
Star Tribune
Menthol Limits: Ban Could Close Vaping Escape Hatch for Smokers
Almost half a million people in our country die from smoking-related illnesses every year. But instead of helping people quit, anti-smoking activists seem to prioritize…